Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients - The VENUS study -

Circulation Journal

Volumn 76, Issue 11, 2012, Pages 2662-2672

  Lee, Stephen Wai Luen ^a   Hau, William Kong To ^a   Kong, Shun Ling ^a   Chan, Kelvin K W ^a   Chan, Pak Hei ^a   Lam, Simon C C ^a   Tam, Frankie C C ^a   Wong, Michael K L ^a   Chan, Carmen W S ^a   Lam, Yui Ming ^a   Tse, Hung Fat ^a   Chan, Raymond H W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Plaque composition; Statin; Virtual histology

Indexed keywords

ATORVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; LOW DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHOTOCHEMICAL INTERNALIZATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS;

AGED; ANTICHOLESTEREMIC AGENTS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; PYRROLES; TIME FACTORS;

EID: 84869118379     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0325     Document Type: Article

References (40)

1. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al; for the Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Eng J Med 2005; 352: 1425-1435.
2. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al; for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Eng J Med 2004; 350: 1495-1504.
3. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, et al. Regression of coronary artery disease as a result of intensive lipidlowering therapy in men with high levels of apolipoprotin B. N Engl J Med 1990; 323: 1289-1298.
4. Takagi T, Yoshida K, Akasaka T, Hozumi T, Morioka S, Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 1997; 79: 1673-1676.
5. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001; 104: 387-392.
6. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: A serial intravascular ultrasound study. Circulation 2004; 110: 265-270.
7. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata, T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: The ESTABLISH Study. Circulation 2004; 110: 1061-1068.
8. Nissen SE, Tuzcu EM, Schoenhagen P, Brown G, Ganz P, Vogel RA, et al; REVERSAL Investigators. Effects of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
9. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballabtybe CM, et al; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-1565.
10. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30: 1282-1292.
11. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200-2206.
12. Nasu K, Tsuchikane E, Katoh O, Vince G, Virmani R, Surmely JF, et al. Accuracy of in vivo coronary plaque morphology assessment: A validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006; 47: 2405-2412.
13. Takayama T, Hiro T, Yamagishi M, Daida H, Hirayama A, Saito S, et al. Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: Multicenter coronary atherosclerosis study measuring effects rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Circ J 2009; 73: 2110-2117.
14. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: JAPANACS investigators. J Am Coll Cardiol 2009; 54: 293-302.
15. Robinson JG, Smith B, Maheshwari N, Schrott H. Pleiotropic effects of statins: Benefit beyond cholesterol reduction? J Am Coll Cardiol 2005; 46: 855-862.
16. Kawasaki M, Takatsu H, Noda T, Sano K, Ito Y, Hayakawa K, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002; 105: 2487-2492.
17. Ogasawara D, Shite J, Shinke T, Watanabe S, Otake H, Tanino Y, et al. Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus. Circ J 2009; 73: 343-351.
18. Serruys PW, García-García HM, Buszman P, Erne P, Verheye S, Aschermann M, et al; for the Integrated Biomarker and Imaging Study-2 Investigators. Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008; 118: 1172-1182.
19. Nozue T, Yamamto S, Tohyama S, Umezawa S, Kunishima T, Sato A, et al. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis. Am Heart J 2012; 163: 191-199.
20. Toi T, Taguchi I, Yoneda S, Kageyama M, Kikuchi A, Tokura M, et al. Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque: Comparison with atorvastatin. Circ J 2009; 73: 1466-1472.
21. Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH, et al. Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. J Am Coll Cardiol Intv 2009; 2: 679-688.
22. Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, et al. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. J Am Coll Cardiol Intv 2009; 2: 689-696.
23. Fujiwara H, Fujita H, Zhou X, Minatoguchi S, Tsuchiya K, Murata I, et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound FREE. J Am Coll Cardiol 2005; 45: 1946-1953.
24. Kovarnik T, Mintz GS, Skalicka H, Kral A, Horak J, Skulec R, et al. Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: Heaven Study. Circ J 2012; 76: 176-183.
25. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, et al. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 Fluorodeoxyglucose uptake in atherosclerotic plaques on Positron Emission Tomography/Computed Tomography: A randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Clin Ther 2010; 32: 2337-2347.
26. Van Herck J, De Meyer G, Ennekens G, Van Herck P, Herman A, Vrints C. Validation of in vivo plaque characterization by virtual histology in a rabbit model of atherosclerosis. EuroIntervention 2009; 5: 149-156.
27. Thim T, Hagensen MK, Wallace-Bradley D, Granada JF, Kaluza GL, Drouet L, et al. Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease. Circ Cardiovasc Imaging 2010; 3: 384-391.
28. Otagiri K, Tsutsui H, Kumazaki S, Miyashita Y, Aizawa K, Koshikawa M, et al. Early intervention with Rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: Analysis of the plaque using backscatter IVUS (ELAN Study). Circ J 2011; 75: 633-641.
29. Okubo M, Kawasaki M, Ishihara Y, Takeyama U, Yasuda S, Kubota T, et al. Tissue characterization of coronary plaques: Comparison of integrated backscatter intravascular ultrasound with virtual histology intravascular ultrasound. Circ J 2008; 72: 1631-1639.
30. Amano T, Matsubara T, Uetani T, Kato M, Kato B, Yoshida T, et al. Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: An integrated backscatter intravascular ultrasound study. Atherosclerosis 2010; 218: 110-116.
31. Ko YG, Son JW, Park SM, Kim JS, Choi D, Hong MK, et al. Effect of vessel size on lipid content of coronary plaques assessed by integrated backscatter intravascular ultrasound. Circ J 2010; 74: 754-759.
32. Chinali M, Romano C, Rocco A, Galderisi M, Betocchi S, De Simone G. Depth variation bias and interaction with gain setting in ultrasonic tissue characterization by integrated backscatter analysis. J Am Soc Echocardiogr 2003; 16: 54-60.
33. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. Circulation 2002; 106: 1077-1082.
34. Schmermund A, Achenbach S, Budde T, Buziashvili Y, Forster A, Friedrich G, et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, doubleblind trial. Circulation 2006; 113: 427-437.
35. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation 2005; 112: 563-571.
36. Rodriguez-Granillo GA, Garcia-Garcia HM, McFadden EP, Valgimigli M, Aoki J, de Feyter P, et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 2005; 46: 2038-2042.
37. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-1791.
38. Pitt B, Mancini GB, Ellis SG, Rosman HS, Park JS, McGovern ME. Pravastatin Limitation of Atherosclerosis in the coronary arteries (PLAC-1): Reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 1995; 26: 1133-1139.
39. Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, et al; The LIPID Study investigators. Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial. Circulation 2002; 105: 1162-1169.
40. Patel TN, Shishehbor MH, Bhatt DL. A review of high-dose statin therapy: Targeting cholesterol and inflammation in atherosclerosis. Eur Heart J 2007; 28: 664-672.